Corbus Pharmaceuticals Holdings, Inc. (CRBP) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 1.97 |
| FCF Yield | -35.7% |
| Sector P/E (Healthcare) | 21.7 |
CRBP overview · CRBP earnings · CRBP KPIs · CRBP investor relations · CRBP ownership · CRBP peers · CRBP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.